Biotech firm abandons traditional treasury playbook in favor of cryptocurrencies. A cancer drug developer has rocked Wall Street by implementing what is perhaps the most audacious crypto treasury stra...
A rare look into how the new, popular dev tool is built, and what it might mean for the future of software building with AI. Exclusive. Claude Code has taken the developer world by storm since being m...
